The ticker symbol TTRx corresponds to Turn Therapeutics Inc., a biopharmaceutical enterprise specializing in the development of innovative anti-infective, dermatological, and wound care products. The company leverages proprietary drug delivery technologies to create advanced topical solutions designed to address complex microbial challenges and tissue regeneration hurdles. Investors track this equity ticker for developments regarding clinical milestones, regulatory approvals, and commercial distribution agreements.